Published in Infect Immun on August 01, 1999
Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J Immunol (2009) 2.09
The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin Microbiol Rev (2004) 1.93
Granulocyte CEACAM3 is a phagocytic receptor of the innate immune system that mediates recognition and elimination of human-specific pathogens. J Exp Med (2004) 1.37
Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection. Mucosal Immunol (2010) 1.35
Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17beta-estradiol-treated mice. Vaccine (2008) 1.26
Mouse strain-dependent differences in susceptibility to Neisseria gonorrhoeae infection and induction of innate immune responses. Infect Immun (2009) 1.24
Neisseria gonorrhoeae kills carcinoembryonic antigen-related cellular adhesion molecule 1 (CD66a)-expressing human B cells and inhibits antibody production. Infect Immun (2005) 1.24
Vaccines for gonorrhea: can we rise to the challenge? Front Microbiol (2011) 1.16
Vaccines against gonorrhea: current status and future challenges. Vaccine (2013) 1.10
Pilin gene variation in Neisseria gonorrhoeae: reassessing the old paradigms. FEMS Microbiol Rev (2009) 1.08
New concepts in immunity to Neisseria gonorrhoeae: innate responses and suppression of adaptive immunity favor the pathogen, not the host. Front Microbiol (2011) 1.08
Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-β-dependent mechanisms. Mucosal Immunol (2012) 1.00
Expression of homing receptors on IgA1 and IgA2 plasmablasts in blood reflects differential distribution of IgA1 and IgA2 in various body fluids. Clin Vaccine Immunol (2010) 0.97
A Bayesian approach to uncertainty analysis of sexually transmitted infection models. Sex Transm Infect (2009) 0.96
Generation of female genital tract antibody responses by local or central (common) mucosal immunization. Infect Immun (2000) 0.95
Regulatory T cells are locally induced during intravaginal infection of mice with Neisseria gonorrhoeae. Infect Immun (2008) 0.94
Immunogenicity of gonococcal transferrin binding proteins during natural infections. Infect Immun (2004) 0.93
Fur-mediated activation of gene transcription in the human pathogen Neisseria gonorrhoeae. J Bacteriol (2012) 0.93
Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development. Crit Rev Microbiol (2016) 0.87
Identification and characterization of gonococcal iron transport systems as potential vaccine antigens. Future Microbiol (2008) 0.85
Immunogenetic correlates of Neisseria gonorrhoeae infection in adolescents. Sex Transm Dis (2008) 0.83
Neisseria gonorrhoeae induces a tolerogenic phenotype in macrophages to modulate host immunity. Mediators Inflamm (2013) 0.81
Conserved regions from Neisseria gonorrhoeae pilin are immunosilent and not immunosuppressive. Infect Immun (2007) 0.81
Neisseria gonorrhoeae Modulates Immunity by Polarizing Human Macrophages to a M2 Profile. PLoS One (2015) 0.81
A comparative analysis of gene expression patterns and cell phenotypes between cervical and peripheral blood mononuclear cells. PLoS One (2009) 0.79
Contrasting within- and between-host immune selection shapes Neisseria Opa repertoires. Sci Rep (2014) 0.77
The genes that encode the gonococcal transferrin binding proteins, TbpB and TbpA, are differentially regulated by MisR under iron-replete and iron-depleted conditions. Mol Microbiol (2016) 0.77
The reproductive cycle is a pathogenic determinant during gonococcal pelvic inflammatory disease in mice. Mucosal Immunol (2015) 0.77
The relationship between the symptoms of female gonococcal infections and serum progesterone level and the genotypes of Neisseria gonorrhoeae multi-antigen sequence type (NG-MAST) in Wuhan, China. Eur J Clin Microbiol Infect Dis (2010) 0.76
Diffusion of antibiotics through the PilQ secretin in Neisseria gonorrhoeae occurs through the immature, sodium dodecyl sulfate-labile form. J Bacteriol (2015) 0.76
Gonorrhea - an evolving disease of the new millennium. Microb Cell (2016) 0.75
ATP Induces IL-1β Secretion in Neisseria gonorrhoeae-Infected Human Macrophages by a Mechanism Not Related to the NLRP3/ASC/Caspase-1 Axis. Mediators Inflamm (2016) 0.75
Characterisation of the Immunomodulatory Effects of Meningococcal Opa Proteins on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells. PLoS One (2016) 0.75
Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model. Mucosal Immunol (2017) 0.75
Refinement of immunizing antigens to produce functional blocking antibodies against the AniA nitrite reductase of Neisseria gonorrhoeae. PLoS One (2017) 0.75
The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol (1987) 5.30
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A (1993) 4.49
Neisseria gonorrhoeae and neisseria meningitidis: extracellular enzyme cleaves human immunoglobulin A. Science (1975) 3.27
Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J Infect Dis (1985) 2.78
Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun (1993) 2.58
Variation and control of protein expression in Neisseria. Annu Rev Microbiol (1990) 2.49
Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun (1997) 2.49
Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum. J Exp Med (1986) 2.40
Local antibody response to poliovaccine in the human female genital tract. J Immunol (1973) 2.30
Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect Immun (1997) 2.01
Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection. J Clin Invest (1989) 1.98
Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol (1995) 1.89
Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science (1992) 1.69
Secretory IgA antibodies in the urethral exudate of men with uncomplicated urethritis due to Neisseria gonorrhoeae. J Infect Dis (1973) 1.65
Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment. J Clin Invest (1981) 1.62
Inhibition of adherence of Neisseria gonorrhoeae by human genital secretions. J Clin Invest (1977) 1.61
Effect of local infection and oral contraception on immunoglobulin levels in cervical mucus. Infect Immun (1975) 1.59
Efficacy trial of a parenteral gonococcal pilus vaccine in men. Vaccine (1991) 1.50
Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand J Immunol (1997) 1.48
Lymphoglandular complexes of the colon: structure and distribution. Histopathology (1986) 1.46
Secretory IgA antibody responses to Neisseria gonorrhoeae in the genital secretions of infected females. J Infect Dis (1976) 1.46
Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: effects of concomitant infections. J Infect Dis (1998) 1.45
Immunoglobulin levels and antibody to Candida albicans in human cervicovaginal secretions. Clin Exp Immunol (1972) 1.45
Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J Infect Dis (1995) 1.40
Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans. Infect Immun (1998) 1.36
Assay of human IgA subclass antibodies in serum and secretions by means of monoclonal antibodies. J Immunol Methods (1986) 1.32
Humoral immune response to the class 3 outer membrane protein during the course of meningococcal disease. Infect Immun (1993) 1.30
Specific immune response in humans following rectal delivery of live typhoid vaccine. Vaccine (1990) 1.27
Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization. Immunology (1990) 1.25
Sexually transmitted diseases and risk of HIV infection. Acta Derm Venereol (1996) 1.22
Secretory antibody response of the cervix to infection with Neisseria gonorrhoeae. Br J Vener Dis (1979) 1.22
Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain. Infect Immun (1996) 1.17
Genital antibody response to a parenteral gonococcal pilus vaccine. Infect Immun (1982) 1.14
Serum and secretory antibody responses to Neisseria gonorrhoeae in patients with gonococcal infections. Br J Vener Dis (1976) 1.09
HIV and other sexually transmitted diseases at a rural hospital in Zimbabwe. Genitourin Med (1993) 1.09
Rectal immunization for induction of specific antibody in the genital tract of women. J Clin Immunol (1997) 1.08
Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit. Infect Immun (1993) 1.06
Persistence of serum and salivary antibody responses after oral immunization with a bacterial protein antigen genetically linked to the A2/B subunits of cholera toxin. Infect Immun (1996) 1.06
Some immunological properties of human cervical and vaginal secretions. Gynecol Invest (1972) 1.06
Antibodies to Neisseria gonorrhoeae: a study of the urethral exudates of 232 men. J Infect Dis (1979) 1.05
Case-control study of sexually transmitted diseases as cofactors for HIV-1 transmission. Int J STD AIDS (1996) 0.99
Determinants of emergence of antibiotic-resistant Neisseria gonorrhoeae. J Infect Dis (1989) 0.99
Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis. Infect Immun (1995) 0.97
Colonization in the rectum and uterine cervix with group B streptococci may induce specific antibody responses in cervical secretions of pregnant women. Infect Immun (1996) 0.95
The sialylation of gonococcal lipopolysaccharide by host factors: a major impact on pathogenicity. FEMS Microbiol Lett (1992) 0.94
Lymphoglandular complexes of the normal colon: histochemistry and immunohistochemistry. Ir J Med Sci (1987) 0.84
Cholera toxin inhibits T cell receptor signaling by covalent modification of the CD3-zeta subunit. J Immunol (1993) 0.78
Condom use to prevent incident STDs: the validity of self-reported condom use. Sex Transm Dis (1995) 5.94
The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol (1987) 5.30
Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol (2008) 5.28
Studies on the bacteremia of bacterial endocarditis. JAMA (1967) 5.00
Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital-Cornell Medical Center. Arch Intern Med (1970) 4.93
Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med (1988) 4.81
Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol (1987) 4.53
Protein antigens of Streptococcus mutans: purification and properties of a double antigen and its protease-resistant component. Infect Immun (1980) 4.36
The physician's responsibility toward hopelessly ill patients. A second look. N Engl J Med (1989) 4.20
Parental monitoring: association with adolescents' risk behaviors. Pediatrics (2001) 4.15
The mucosal immune system: from fundamental concepts to vaccine development. Vaccine (1992) 3.99
Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med (1988) 3.71
Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J (2000) 3.61
Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol (2003) 3.50
Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic. J Clin Microbiol (1995) 3.47
National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA (1990) 3.25
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int (2007) 3.17
Characterisation of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c. Arch Oral Biol (1978) 3.03
Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum (1976) 2.97
Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst (2000) 2.82
Nonculture tests for genital tract chlamydial infection. What does the package insert mean, and will it mean the same thing tomorrow? Sex Transm Dis (1992) 2.80
Ingestion of Streptococcus mutans induces secretory immunoglobulin A and caries immunity. Science (1976) 2.78
Partner type and condom use. AIDS (2000) 2.78
Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest (1999) 2.77
Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect Immun (1989) 2.74
Immunization with purified protein antigens from Streptococcus mutans against dental caries in rhesus monkeys. Infect Immun (1981) 2.72
Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA (1995) 2.71
Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J Clin Invest (1978) 2.64
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines. J Virol (1998) 2.63
Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs. J Clin Microbiol (1995) 2.62
Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun (1993) 2.58
Pathogenic species of the genus Haemophilus and Streptococcus pneumoniae produce immunoglobulin A1 protease. Infect Immun (1979) 2.57
The rapid test paradox: when fewer cases detected lead to more cases treated: a decision analysis of tests for Chlamydia trachomatis. Sex Transm Dis (1999) 2.52
Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J Infect Dis (1997) 2.50
Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol Rev (1988) 2.50
Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. Microb Pathog (1997) 2.41
IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc Natl Acad Sci U S A (1987) 2.37
A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group. N Engl J Med (1991) 2.30
Antigens of Treponema pallidum recognized by IgG and IgM antibodies during syphilis in humans. J Infect Dis (1985) 2.29
Epidemiology of gonorrhea: distribution and temporal changes in auxotype/serovar classes of Neisseria gonorrhoeae. Sex Transm Dis (1987) 2.27
Secretory component of epithelial cells is a surface receptor for polymeric immunoglobulins. J Exp Med (1978) 2.26
Leukocyte bactericidal activity in chronic granulomatous disease: correlation of bacterial hydrogen peroxide production and susceptibility to intracellular killing. J Bacteriol (1969) 2.25
Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA (1983) 2.25
Leukocyte function in chronic granulomatous disease of childhood. Studies on a seventeen year old boy. Am J Med (1969) 2.23
IgA1 proteases from Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and Streptococcus sanguis: comparative immunochemical studies. J Immunol (1980) 2.23
Gonococcal infections. Ann Intern Med (1985) 2.23
Fluorescent monoclonal antibody for confirmation of Neisseria gonorrhoeae cultures. J Clin Microbiol (1987) 2.21
Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature. Rev Infect Dis (1983) 2.08
Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA (1996) 2.07
Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine (1995) 2.06
Immunoglobulin M and secretory immunoglobulin A: presence of a common polypeptide chain different from light chains. Science (1971) 2.03
IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med (1988) 2.02
Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol (2000) 2.02
Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance. Sex Transm Dis (1999) 1.99
Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol (2001) 1.95
Gonorrhea in the HIV era: a reversal in trends among men who have sex with men. Am J Public Health (2001) 1.94
Immunoglobulin A (IgA). Methods Enzymol (1985) 1.94
The effect of an NADH oxidase inhibitor (hydrocortisone) on polymorphonuclear leukocyte bactericidal activity. J Clin Invest (1970) 1.91
A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells. J Immunol Methods (1988) 1.91
Mechanical failure of the latex condom in a cohort of women at high STD risk. Sex Transm Dis (1999) 1.90
Role of the vegetation in experimental Streptococcus viridans endocarditis. Infect Immun (1974) 1.89
Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol (1995) 1.89
Confirming positive results of nucleic acid amplification tests (NAATs) for Chlamydia trachomatis: all NAATs are not created equal. J Clin Microbiol (2005) 1.88
Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int (1997) 1.88
Naturally occurring secretory immunoglobulin A antibodies to Streptococcus mutans in human colostrum and saliva. Infect Immun (1976) 1.85
Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J Control Release (2001) 1.85
Synergistic effect of IL-4 and IFN-gamma on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells. J Immunol (1990) 1.82
IgA-induced eosinophil degranulation. J Immunol (1989) 1.82
Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J Clin Microbiol (1985) 1.80
Effectiveness of an intervention promoting the female condom to patients at sexually transmitted disease clinics. Am J Public Health (2000) 1.80
Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis (1994) 1.78
Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J Immunol (1984) 1.78
Methylene blue chromoendoscopy for detection of short-segment Barrett's esophagus. Gastrointest Endosc (2001) 1.77
Regulation of IgA synthesis and immune response by T cells and interleukins. J Clin Immunol (1989) 1.76
Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to the fluoroquinolones. J Infect Dis (1997) 1.75
Affinity and specificity of the interactions between Streptococcus mutans antigen I/II and salivary components. J Dent Res (1994) 1.75
Antimicrobial therapy of experimental enterococcal endocarditis. Antimicrob Agents Chemother (1975) 1.75
Active commuting to and from school and BMI in elementary school children-preliminary data. Child Care Health Dev (2005) 1.74
Murine model for evaluation of protective immunity to influenza virus. Vaccine (1993) 1.73
Tissue origins of human polymeric and monomeric IgA. J Immunol (1982) 1.73
Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol (1994) 1.72
Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit. Infect Immun (1996) 1.71
Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest (1986) 1.70
Patients attending STD clinics in an evolving health care environment. Demographics, insurance coverage, preferences for STD services, and STD morbidity. Sex Transm Dis (1997) 1.69
Characterization of antibodies to the native human collagens and to their component alpha chains in the sera and the joint fluids of patients with rheumatoid arthritis. Immunochemistry (1976) 1.67
Purification and properties of a protein surface antigen of Streptococcus mutants. Microbios (1979) 1.67
Prevalence and persistence of Neisseria cinerea and other Neisseria spp. in adults. J Clin Microbiol (1988) 1.67
The human IgA system: a reassessment. Clin Immunol Immunopathol (1986) 1.64
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. J Infect Dis (1998) 1.64
Characterization of patients accepting and refusing routine, voluntary HIV antibody testing in public sexually transmitted disease clinics. Sex Transm Dis (1994) 1.63
Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues. Virology (1999) 1.63
Resistance of some common fungi to gamma irradiation. Appl Environ Microbiol (1988) 1.63
Studies on human secretory immunoglobulin A. II. Subunit structure. J Immunol (1972) 1.62
Immunisation with a purified protein from Streptococcus mutans against dental caries in rhesus monkeys. Lancet (1980) 1.61
Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes. J Infect Dis (2000) 1.61
Differential homing commitments of antigen-specific T cells after oral or parenteral immunization in humans. J Immunol (1999) 1.60